|  | - | HPV % | + | % |  |
---|---|---|---|---|---|---|
MSI | MSS | 187 | 94.4 | 31 | 93.9 | 1 |
 | MSI | 11 | 5.6 | 2 | 6.1 |  |
age (median) | Â | 56 | Â | 60 | Â | 0.05 |
gender | male | 119 | 59.8 | 23 | 69.7 | 0.337 |
 | female | 80 | 40.2 | 10 | 30.3 |  |
grade of differentiation | good | 83 | 44.1 | 12 | 40.0 | 0.764 |
 | average | 87 | 46.8 | 16 | 53.3 |  |
 | poor | 17 | 9.0 | 2 | 6.7 |  |
location | proximal | 57 | 30.3 | 13 | 39.4 | 0.565 |
 | distal | 70 | 37.2 | 10 | 30.3 |  |
 | rectum | 61 | 32.4 | 10 | 30.3 |  |
lymph nodes | + | 97 | 86.6 | 82 | 89.1 | 0.670 |
 | - | 15 | 13.4 | 10 | 10.9 |  |
stage | I | 25 | 13.0 | 3 | 9.7 | 0.265 |
 | II | 55 | 28.7 | 13 | 41.9 |  |
 | III | 62 | 32.3 | 12 | 38.7 |  |
 | IV | 50 | 26.0 | 3 | 9.7 |  |
adjuvant | yes | 62 | 37.8 | 22 | 73.3 | 0.303 |
 | no | 102 | 62.2 | 8 | 26.7 |  |